Genetics

It is game over for 23andMe, and rightly so

The market for personal genome services is facing a reality check. While the most prominent and innovative company 23andMe has flourished so far, in the past few years many of its competitors have gone out of business. Now, ...

Cardiology

USPSTF: evidence lacking for ankle brachial index screening

(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) has found that there is currently insufficient evidence to weigh the benefits and harms of use of the ankle-brachial index (ABI) for screening for peripheral ...

Diseases, Conditions, Syndromes

New risk score spots patients at high risk of serious blood clots

A new risk prediction tool can identify patients at high risk of serious blood clots (known as venous thromboembolism) who might need preventative treatment, says a study published in the British Medical Journal today.

page 1 from 4